NCT03867682
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03867682
Title Venetoclax and Lintuzumab-Ac225 in AML Patients
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Actinium Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California RECRUITING Los Angeles California 90095 United States Details
University of Louisville RECRUITING Louisville Kentucky 40202 United States Details
Ochsner Clinic Foundation RECRUITING New Orleans Louisiana 70121 United States Details
Weill Cornell Medicine RECRUITING New York New York 10021 United States Details
Fred Hutchinson Cancer Research Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field